Live news related to NYXOAH stock (BE0974358906): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on NYXOAH mainly cover M&A activity, earnings publications et analyst notes. The stock trades at €1,24 on Euronext Paris, down 4,62% at the last update. This page lists the articles published on NYXOAH stock to track the share price, company announcements and any item likely to influence market perception.
In the second quarter of 2026, Nyxoah reported a global net revenue of €7.7M, marking a sequential increase of 21% from Q1. The medical technology gro…
Medical technology company Nyxoah will host an Investor Day on Wednesday, July 8 in New York, focusing on its growth strategy. The leadership and boar…
Nyxoah announced on Wednesday the release of the second tranche of its financing from the European Investment Bank (EIB), amounting to $15 million. Th…
On Monday, Nyxoah received the 2026 UK Galien Award for its Genio technology, a hypoglossal nerve stimulation therapy aimed at treating obstructive sl…
The stock of the Belgian medical technology company gains some ground in early afternoon trading within a distinctly bullish European market. The rebo…
On Wednesday, medical technology company Nyxoah finalized its public stock offering in the United States, involving 55.2 million shares priced at $1.7…
On Thursday, medical technology company Nyxoah announced the launch of a public offering in the United States, which may include a private offering to…
Nyxoah announced on Thursday the launch of a succession process for its CEO position. Olivier Taelman, who has led the company for seven years, is ste…
On Wednesday, Nyxoah participated in an exclusive event at LégiaPark, the life sciences innovation campus located in Liège, bringing together around f…
Nyxoah reported a net revenue of 6.4 million euros in the first quarter of 2026, up 13% sequentially from the previous quarter, driven by the expansio…
